Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: GENFIT

Market Cap 461M 534M 425M 398M 745M 50.74B 757M 5.02B 1.96B 24.7B 2B 1.96B 85.52B P/E Ratio 2025
-3.06x
P/E Ratio 2026 * 48.7x
Enterprise Value 406M 471M 374M 351M 657M 44.72B 667M 4.42B 1.72B 21.77B 1.77B 1.73B 75.37B EV / Sales 2025
2.34x
EV / Sales 2026 * 4.35x
Free-Float
86.88%
Yield 2025 *
-
Yield 2026 * -
1 day+3.25%
1 week+6.23%
Current month+5.86%
1 month+3.72%
3 months+9.71%
6 months+77.80%
Current year+80.59%
1 week 8.15
Extreme 8.15
9.39
1 month 8.15
Extreme 8.15
9.39
Current year 5.06
Extreme 5.055
9.67
1 year 3.43
Extreme 3.432
9.67
3 years 3.3
Extreme 3.305
9.67
5 years 2.96
Extreme 2.964
9.67
10 years 2.96
Extreme 2.964
21.74
Manager TitleAgeSince
Chief Executive Officer 58 15/09/2019
Director of Finance/CFO 52 21/04/2021
Chief Tech/Sci/R&D Officer - 26/11/2025
Director TitleAgeSince
Chairman 70 15/06/2017
Director/Board Member 54 14/09/1999
Director/Board Member 58 15/06/2017
Change 5-day change 1-year change 3-year change Capi.($)
+3.25%+6.23% - - 534M
-0.35%+0.97%-13.80%-13.25% 43.03B
+3.11%+3.11%+279.08%+501.52% 32.71B
+0.22%-1.08%+15.66%-15.65% 30.29B
+1.62%-2.08%-1.91%+24.64% 29.4B
+4.09%+0.93%+12.97%+20.22% 25.08B
+1.14%+3.62% - - 13.54B
-1.63%+2.88%+56.69%+113.41% 13.35B
-0.40%-1.29%+6.23%+7.63% 12.97B
-0.74%-1.62%+105.89%+74.92% 12.11B
Average +1.03%+1.45%+57.60%+89.18% 23.61B
Weighted average by Cap. +1.06%+1.48%+57.30%+96.08%

Financials

2025 2026 *
Net sales 66.82M 77.36M 61.57M 57.63M 108M 7.35B 110M 727M 283M 3.58B 290M 284M 12.39B 95.2M 110M 87.72M 82.11M 154M 10.48B 156M 1.04B 404M 5.1B 414M 405M 17.66B
Net income -8.3M -9.61M -7.65M -7.16M -13.42M -914M -13.63M -90.34M -35.22M -445M -36.08M -35.31M -1.54B 18.31M 21.19M 16.87M 15.79M 29.59M 2.01B 30.05M 199M 77.66M 981M 79.54M 77.85M 3.4B
Net Debt -54.72M -63.36M -50.42M -47.2M -88.46M -6.02B -89.83M -595M -232M -2.93B -238M -233M -10.15B -46.87M -54.26M -43.19M -40.43M -75.76M -5.16B -76.93M -510M -199M -2.51B -204M -199M -8.69B
Logo GENFIT
GENFIT is a biopharmaceutical company in late-stage development focused on the discovery and development of innovative therapeutic and diagnostic solutions in the field of liver diseases, particularly of metabolic origin, where unmet medical needs are considerable, in particular due to a lack of approved treatments. GENFIT is a leading innovator in the field of nuclear receptor-based drug discovery with a rich history and a solid scientific heritage spanning nearly two decades. The company has offices in Lille, Paris, Zurich and Cambridge, MA (USA).
Employees
188
Date Price Change
12/06/26 9.210 +3.25%
11/06/26 8.920 +6.19%
10/06/26 8.400 -0.83%
09/06/26 8.470 -2.98%
08/06/26 8.730 +0.69%
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
9.260EUR
Average target price
14.00EUR
Spread / Average Target
+51.19%

Quarterly revenue - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!